NSD1
Summary: This gene encodes a protein containing a SET domain, 2 LXXLL motifs, 3 nuclear translocation signals (NLSs), 4 plant homeodomain (PHD) finger regions, and a proline-rich region. The encoded protein enhances androgen receptor (AR) transactivation, and this enhancement can be increased further in the presence of other androgen receptor associated coregulators. This protein may act as a nucleus-localized, basic transcriptional factor and also as a bifunctional transcriptional regulator. Mutations of this gene have been associated with Sotos syndrome and Weaver syndrome. One version of childhood acute myeloid leukemia is the result of a cryptic translocation with the breakpoints occurring within nuclear receptor-binding Su-var, enhancer of zeste, and trithorax domain protein 1 on chromosome 5 and nucleoporin, 98-kd on chromosome 11. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008].
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| nuclear receptor binding SET domain protein 1 | MIM:606681 | Ensembl:ENSG00000165671 | HGNC:HGNC:14234 | PA31790 | 5q35.3 |
GO terms in NSD1
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| MF | IDA | GO:0000978 | RNA polymerase II proximal promoter sequence-specific DNA binding |
| MF | ISS | GO:0003682 | chromatin binding |
| MF | IDA | GO:0003712 | transcription coregulator activity |
| MF | ISS | GO:0003714 | transcription corepressor activity |
| MF | IPI | GO:0005515 | protein binding |
| MF | IDA | GO:0008270 | zinc ion binding |
| MF | TAS | GO:0018024 | histone-lysine N-methyltransferase activity |
| MF | ISS | GO:0030331 | estrogen receptor binding |
| MF | ISS | GO:0042799 | histone methyltransferase activity (H4-K20 specific) |
| MF | ISS | GO:0042974 | retinoic acid receptor binding |
| MF | ISS | GO:0046965 | retinoid X receptor binding |
| MF | ISS | GO:0046966 | thyroid hormone receptor binding |
| MF | IDA | GO:0046975 | histone methyltransferase activity (H3-K36 specific) |
| MF | ISS | GO:0046975 | histone methyltransferase activity (H3-K36 specific) |
| MF | IDA | GO:0050681 | androgen receptor binding |
| CC | TAS | GO:0005654 | nucleoplasm |
| CC | IEA | GO:0005694 | chromosome |
| BP | ISS | GO:0000122 | negative regulation of transcription by RNA polymerase II |
| BP | IMP | GO:0000414 | regulation of histone H3-K36 methylation |
| BP | IEA | GO:0006351 | transcription, DNA-templated |
| BP | IEA | GO:0010452 | histone H3-K36 methylation |
| BP | ISS | GO:0016571 | histone methylation |
| BP | IMP | GO:0033135 | regulation of peptidyl-serine phosphorylation |
| BP | IEA | GO:0034770 | histone H4-K20 methylation |
| BP | IDA | GO:0045893 | positive regulation of transcription, DNA-templated |
| BP | IMP | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding |
Gene expression in normal tissue: NSD1
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in NSD1
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| wikipathways | WP2369 | Histone Modifications |
| wikipathways | WP3651 | Pathways Affected in Adenoid Cystic Carcinoma |
| kegg | hsa00310 | Lysine degradation - Homo sapiens (human) |
| netpath | Pathway_AndrogenReceptor | AndrogenReceptor |
| reactome | R-HSA-3214841 | PKMTs methylate histone lysines |
| reactome | R-HSA-3247509 | Chromatin modifying enzymes |
| reactome | R-HSA-4839726 | Chromatin organization |
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD512 | nutlin 3 | 1 |
| iGMDRD654 | SL 0101-1 | 1 |
| iGMDRD126 | Tipifarnib | 3 |
| iGMDRD564 | GSK-650394 | 1 |
| iGMDRD232 | FTI-277 | 1 |
| iGMDRD781 | Sirolimus | 5 |
| iGMDRD116 | CD437 | 3 |
| iGMDRD193 | Fqi1 | 1 |
| iGMDRD280 | CYTOCHALASIN B | 2 |
| iGMDRD394 | BX-795 | 1 |
| iGMDRD466 | Chaetocin | 2 |
| iGMDRD260 | FQI-2 | 3 |
| iGMDRD109 | Gefitinib | 1 |
| iGMDRD137 | Indisulam | 3 |
| iGMDRD52 | Rotenone | 3 |
| iGMDRD870 | BRD63610 | 1 |
| iGMDRD705 | Nakiterpiosin | 3 |
| iGMDRD100 | Zebularine | 3 |
| iGMDRD286 | Nsc 632839 | 3 |
| iGMDRD886 | Compound 1541A | 3 |
| iGMDRD60 | Quinoclamine | 3 |
| iGMDRD64 | Parbendazole | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in NSD1
Copyright © 2018 Modellab | All Rights Reserved
Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.